Professional Societies Delineate Concerns, Offer Recommendations Regarding Interim Pricing for Molecular Tests
Monday, May 13, 2013 - 09:00
in Health & Medicine
Today a coalition representing over 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States released a joint statement regarding new Medicare prices for those tests.